Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-029436
Filing Date
2013-05-21
Accepted
2013-05-21 16:45:21
Documents
1
Period of Report
2013-05-17

Document Format Files

Seq Description Document Type Size
1 JACOB FORM 4 05172013 rrd380548.html 4  
1 JACOB FORM 4 05172013 rrd380548.xml 4 3123
  Complete submission text file 0001181431-13-029436.txt   4875
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

EIN.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O INKINE PHARMACEUTICAL COMPANY INC 425 PARK AVENUE NEW YORK NY 10022
Business Address
JACOB LEONARD S (Reporting) CIK: 0001049713 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 0630
Type: 4 | Act: 34 | File No.: 001-32302 | Film No.: 13862352